Breast cancers cyclin d. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy14

Breast Cell Line, Tumor Tumor Cells, Cultured MCF-7 Cells Mammary Glands, Human Axilla Cell Line Epithelial Cells Cell Nucleus Lymph Nodes Nipples Neoplastic Stem Cells Mammary Glands, Animal Cells, Cultured

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases37

Breast Neoplasms Carcinoma, Ductal, Breast Breast Diseases Neoplasm Invasiveness Neoplasm Metastasis Breast Neoplasms, Male Carcinoma, Lobular Carcinoma, Intraductal, Noninfiltrating Mammary Neoplasms, Experimental Carcinoma Genetic Predisposition to Disease Neoplasms, Hormone-Dependent Ovarian Neoplasms Lymphatic Metastasis Neoplasm Recurrence, Local Lung Neoplasms Cell Transformation, Neoplastic Disease Progression Prostatic Neoplasms Neoplasms Fibrocystic Breast Disease Colonic Neoplasms Bone Neoplasms Stomach Neoplasms Carcinoma, Ductal Carcinoma in Situ Adenocarcinoma Pancreatic Neoplasms Neoplasms, Second Primary Triple Negative Breast Neoplasms Carcinoma, Squamous Cell Inflammatory Breast Neoplasms Mammary Neoplasms, Animal Neovascularization, Pathologic Fibroadenoma Uterine Cervical Neoplasms Colorectal Neoplasms

Chemicals and Drugs80

Cyclin D1 Cyclin D2 Cyclin D3 Cyclin A Cyclin D Cyclin E Cyclin B Cyclin B1 Cyclin A1 Receptors, Estrogen Cyclins Cyclin A2 Receptor, erbB-2 Tamoxifen Cyclin-Dependent Kinase 4 Receptors, Progesterone Cyclin-Dependent Kinases Tumor Markers, Biological Cyclin G1 Cyclin G Neoplasm Proteins Antineoplastic Agents Antineoplastic Agents, Hormonal RNA, Messenger Cyclin-Dependent Kinase 2 Retinoblastoma Protein Estrogen Receptor alpha Cell Cycle Proteins Cyclin C Estrogens Oncogene Proteins CDC2-CDC28 Kinases Tumor Suppressor Proteins RNA, Small Interfering Cyclin B2 Estrogen Antagonists Protein-Serine-Threonine Kinases BRCA2 Protein BRCA1 Protein Tumor Suppressor Protein p53 Proto-Oncogene Proteins Cyclin T Aromatase Inhibitors Cyclin-Dependent Kinase Inhibitor p21 Ki-67 Antigen DNA, Neoplasm Cyclin G2 Estradiol Cyclin H Transcription Factors Estrogen Receptor Modulators Fluorouracil DNA-Binding Proteins Nitriles CDC2 Protein Kinase Cyclin-Dependent Kinase Inhibitor p27 Antibodies, Monoclonal, Humanized Cyclophosphamide RNA, Neoplasm Selective Estrogen Receptor Modulators Nuclear Proteins Antibodies, Monoclonal Epirubicin Receptor, Epidermal Growth Factor Proto-Oncogene Proteins c-akt Anticarcinogenic Agents beta Catenin Enzyme Inhibitors Paclitaxel DNA Primers Antigens, Neoplasm Proto-Oncogene Proteins c-myc Cancer Vaccines Antibiotics, Antineoplastic MicroRNAs Cyclin-Dependent Kinase Inhibitor p16 Triazoles Mucin-1 Antigens, CD24 Phosphatidylinositol 3-Kinases

Analytical, Diagnostic and Therapeutic Techniques and Equipment66

Mammography Prognosis Neoplasm Staging Immunohistochemistry Early Detection of Cancer Mastectomy Risk Factors Chemotherapy, Adjuvant Reverse Transcriptase Polymerase Chain Reaction Survival Analysis Mammary Neoplasms, Experimental Blotting, Western Gene Expression Profiling Antineoplastic Combined Chemotherapy Protocols Case-Control Studies Disease-Free Survival Breast Self-Examination Follow-Up Studies Risk Survival Rate Transfection Prospective Studies Retrospective Studies Risk Assessment Xenograft Model Antitumor Assays Mastectomy, Segmental Odds Ratio Treatment Outcome Incidence Oligonucleotide Array Sequence Analysis Multivariate Analysis Transplantation, Heterologous Tissue Array Analysis Cohort Studies Neoplasm Transplantation Registries Sensitivity and Specificity Immunoenzyme Techniques Ultrasonography, Mammary Polymerase Chain Reaction Tumor Burden Kaplan-Meier Estimate Predictive Value of Tests SEER Program Questionnaires Logistic Models Combined Modality Therapy Models, Biological Breast Implants Flow Cytometry In Situ Hybridization, Fluorescence Reproducibility of Results Gene Knockdown Techniques Neoplasm Grading Mass Screening Radiotherapy, Adjuvant Drug Screening Assays, Antitumor Mammaplasty Confidence Intervals Clinical Trials as Topic Neoadjuvant Therapy Molecular Targeted Therapy Proportional Hazards Models Immunoblotting Genetic Testing Biopsy, Needle

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes52

Gene Expression Regulation, Neoplastic Cell Cycle Cell Proliferation G1 Phase Genes, BRCA1 Cell Division Genes, bcl-1 Postmenopause Drug Resistance, Neoplasm Signal Transduction Genetic Predisposition to Disease Apoptosis Breast Feeding Phosphorylation Premenopause Down-Regulation Mutation S Phase Risk Promoter Regions, Genetic Transfection Menopause Time Factors Genes, erbB-2 Genes, BRCA2 Odds Ratio Up-Regulation Cell Movement Cell Growth Processes RNA Interference Gene Amplification Gene Expression Base Sequence Sensitivity and Specificity Transcription, Genetic Genotype Dose-Response Relationship, Drug Polymorphism, Genetic Germ-Line Mutation Protein Binding DNA Methylation Cell Survival Gene Silencing Mitosis Phenotype Genes, Tumor Suppressor Enzyme Activation Gene Expression Regulation Parity G0 Phase Genes, p53 Alleles

Disciplines and Occupations1

Immunohistochemistry

Information Science7

Survival Rate Incidence Molecular Sequence Data Base Sequence Registries SEER Program Questionnaires

Named Groups2

Survivors European Continental Ancestry Group

Health Care30

Risk Factors Survival Analysis Case-Control Studies Disease-Free Survival Follow-Up Studies Risk Survival Rate Prospective Studies Retrospective Studies Risk Assessment Age Factors Odds Ratio Treatment Outcome Incidence Multivariate Analysis Cohort Studies Registries Sensitivity and Specificity Kaplan-Meier Estimate Predictive Value of Tests SEER Program Questionnaires Logistic Models Reproducibility of Results Mass Screening Confidence Intervals Clinical Trials as Topic Parity Proportional Hazards Models Genetic Testing

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care Geographicals

Cyclin D1 Cyclin D2 Cyclin D3 Breast Cyclin A Cyclin D Cyclin E Breast Neoplasms Cyclin B Cyclin B1 Carcinoma, Ductal, Breast Cyclin A1 Cell Line, Tumor Receptors, Estrogen Cyclins Gene Expression Regulation, Neoplastic Cyclin A2 Receptor, erbB-2 Breast Diseases Tamoxifen Cyclin-Dependent Kinase 4 Cell Cycle Receptors, Progesterone Cyclin-Dependent Kinases Mammography Prognosis Tumor Markers, Biological Neoplasm Invasiveness Neoplasm Metastasis Cell Proliferation Cyclin G1 Cyclin G Neoplasm Proteins Tumor Cells, Cultured Antineoplastic Agents Breast Neoplasms, Male Antineoplastic Agents, Hormonal Neoplasm Staging Immunohistochemistry G1 Phase RNA, Messenger Early Detection of Cancer Cyclin-Dependent Kinase 2 Mastectomy Risk Factors Genes, BRCA1 Mice, Nude Cell Division Genes, bcl-1 Retinoblastoma Protein Postmenopause Chemotherapy, Adjuvant Carcinoma, Lobular Reverse Transcriptase Polymerase Chain Reaction MCF-7 Cells Estrogen Receptor alpha Cell Cycle Proteins Drug Resistance, Neoplasm Cyclin C Carcinoma, Intraductal, Noninfiltrating Signal Transduction Survival Analysis Mammary Neoplasms, Experimental Blotting, Western Carcinoma Estrogens Genetic Predisposition to Disease Oncogene Proteins Gene Expression Profiling Apoptosis Antineoplastic Combined Chemotherapy Protocols Case-Control Studies CDC2-CDC28 Kinases Breast Feeding Phosphorylation Neoplasms, Hormone-Dependent Premenopause Tumor Suppressor Proteins Disease-Free Survival Ovarian Neoplasms Lymphatic Metastasis Down-Regulation RNA, Small Interfering Breast Self-Examination Cyclin B2 Mutation S Phase Neoplasm Recurrence, Local Follow-Up Studies Risk Survival Rate Lung Neoplasms Promoter Regions, Genetic Estrogen Antagonists Protein-Serine-Threonine Kinases Transfection Menopause BRCA2 Protein Cell Transformation, Neoplastic Time Factors

No FAQ available that match "breast cancers cyclin d"